Literature DB >> 7788904

Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.

G T Stavri1, I C Zachary, P A Baskerville, J F Martin, J D Erusalimsky.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) is a hypoxia-inducible direct angiogenic factor. Upregulation of VEGF is thought to mediate many of the angiogenic effects of growth factors that are not direct endothelial cell mitogens. Like VEGF, basic fibroblast growth factor (bFGF) is considered to induce angiogenesis by a direct effect on endothelial cells. This study investigated the possibility that bFGF may also act indirectly by regulating VEGF expression in vascular smooth muscle cells (VSMCs). METHODS AND
RESULTS: Incubation of confluent and quiescent cultures of rabbit VSMCs with bFGF caused a time- and concentration-dependent increase in steady-state levels of VEGF mRNA, as analyzed by Northern blot hybridization. Exposure of VSMCs to a threshold hypoxic stimulus (2.5% O2) caused a modest increase in VEGF mRNA levels. However, the combination of 2.5% O2 with bFGF had a marked synergistic effect. This effect was specific for VEGF as hypoxia did not enhance bFGF-induced expression of the proto-oncogene c-myc. Synergistic upregulation of VEGF mRNA expression also was observed between hypoxia and TGF-beta 1.
CONCLUSIONS: These results suggest that bFGF may promote angiogenesis both by a direct effect on endothelial cells and also indirectly by the upregulation of VEGF in VSMCs. The synergy demonstrated between hypoxia and either bFGF or TGF-beta 1 suggests that multiple diverse stimuli may interact via the upregulation of VEGF expression in VSMCs to amplify the angiogenic response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788904     DOI: 10.1161/01.cir.92.1.11

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  80 in total

Review 1.  Angiogenesis in the corpus luteum.

Authors:  L P Reynolds; A T Grazul-Bilska; D A Redmer
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

Review 2.  Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis?

Authors:  S H Rahimtoola
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

3.  Assessment of internal mammary artery and saphenous vein graft patency and flow reserve using transthoracic Doppler echocardiography.

Authors:  F Chirillo; A Bruni; G Balestra; C Cavallini; Z Olivari; J D Thomas; P Stritoni
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 4.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 5.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

6.  Pattern of pulmonary venous blood flow in the hypoplastic left heart syndrome in the fetus.

Authors:  D J Better; H D Apfel; V Zidere; L D Allan
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

7.  Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications.

Authors:  A Bowling; M Bond; D McKee; M McClay; A P Banning; N Dudley; A Elder; A Martin; I Blackman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

8.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 9.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

10.  Pulmonary and caval flow dynamics after total cavopulmonary connection.

Authors:  K Houlind; E V Stenbøg; K E Sørensen; K Emmertsen; O K Hansen; L Rybro; V E Hjortdal
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.